Ocean Biomedical, Inc. (OCEA)

Ocean Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021
Selling, General & Admin	7.71	28.41
Research & Development	8.41	33.93
Operating Expenses	16.12	62.35
Operating Income	-16.12	-62.35
Other Expense / Income	1.24	-0
Pretax Income	-17.36	-62.34
Net Income	-17.36	-62.34
Shares Outstanding (Basic)	17	17
Shares Outstanding (Diluted)	17	17
Shares Change	0.05%	-
EPS (Basic)	-0.99	-3.57
EPS (Diluted)	-0.99	-3.57
Free Cash Flow	-0.99	-1.05
Free Cash Flow Per Share	-0.06	-0.06
EBITDA	-17.36	-62.34
EBIT	-17.36	-62.34

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).